GlassScriptPhysician profile
Tracy Foster
NPI 1689012965
$5,048.83
in general payments reported to CMS, 2019-2025
30 companies · $866 in 2025
The $866 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,045 · 2022: $982 · 2023: $1,219 · 2024: $938 · 2025: $866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,022.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,022.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,103.49 | 2021-2024 | Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd, Varithena Administration Pack |
| Novartis Pharmaceuticals Corporation | $668.62 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $478.98 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $459.15 | 2021-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $416.19 | 2021-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $237.06 | 2021-2025 | Jardiance |
| Abbott Laboratories | $197.98 | 2022-2025 | Cardiomems |
| Lexicon Pharmaceuticals, INC. | $194.33 | 2023-2024 | Inpefa |
| Pfizer INC. | $166.78 | 2021-2025 | |
| Amarin Pharma, INC. | $149.36 | 2021-2022 | |
| Amgen INC. | $140.38 | 2021-2025 | Repatha, Repatha |
| Novo Nordisk INC | $126.17 | 2023-2025 | Ozempic, Wegovy |
| Cleerly, INC. | $93.70 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Inspire Medical Systems, INC. | $78.00 | 2025 | Inspire |
| Esperion Therapeutics, INC. | $71.40 | 2021-2024 | Nexletol |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $67.52 | 2024-2025 | Eliquis, Camzyos |
| Tactile Systems Technology INC | $59.22 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $41.64 | 2025 | Assure Wcd |
| Endologix LLC | $35.49 | 2022 | |
| Preventice Services, LLC | $32.68 | 2021 | |
| Medtronic, INC. | $31.80 | 2025 | Corevalve Evolut R |
| Alnylam Pharmaceuticals INC. | $26.25 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $25.88 | 2021-2024 | Farxiga |
| Elutia, INC. | $25.72 | 2021-2022 | |
| Irhythm Technologies, INC. | $25.45 | 2024 | Zio Xt Patch, Zio Monitor |
| Heartflow, INC. | $23.72 | 2024 | |
| Sanofi-Aventis U.S. LLC | $21.88 | 2024 | |
| Lilly USA, LLC | $18.29 | 2025 | |
| Janssen Scientific Affairs, LLC | $17.22 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.48 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.